Is preoperative chemotherapy useful for nonmetastatic Wilms' tumor?: Commentary

Nature Clinical Practice Oncology

Volumn 4, Issue 5, 2007, Pages 272-273

  Litten, Jason B ^a   Tomlinson, Gail E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

AUSTRALIA; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FATALITY; HISTOPATHOLOGY; HUMAN; LIVER VENOOCCLUSIVE DISEASE; NEPHRECTOMY; NEPHROBLASTOMA; NORWAY; OVERALL SURVIVAL; PERCUTANEOUS BIOPSY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SURGICAL MORTALITY; SURVIVAL TIME; THERAPY DELAY; UNITED KINGDOM;

EID: 34248554186     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0769     Document Type: Short Survey

References (5)

1. Green DM et al. (1995) The treatment of Wilms tumor: Results of the National Wilms Tumor Studies. Hematol Oncol Clin North Am 9 1267-1274
2. Green DM et al. (1998) Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16: 3744-3751
3. Green DM et al. (1998) Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 16: 237-245
4. Reinhard H et al. (2004) Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral non-metastatic Wilms tumor. Klin Padiatr 216: 132-140
5. D'Angio G (2003) Pre- or post-operative treatment for Wilms' Tumor? Who, what, when, where, how, why and which. Med Pediatr Oncol 41: 545-549